Meridian Bioscience, Inc. Reports Second Quarter and Six Months Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2013 Guidance

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Meridian Bioscience, Inc. (NASDAQ: VIVO):

Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today:

•reported fiscal 2013 second quarter and six months net sales of $47.3 million and $92.6 million, respectively, flat and an increase of 6%, respectively, from the same periods of the prior fiscal year; •reported second quarter operating income of $15.3 million, an increase of 3% over the same period of the prior fiscal year;